Environmental and Genetic Determinants of NPC

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by National Institutes of Health Clinical Center (CC)
Sponsor:
Collaborators:
Academia Sinica
National Taiwan Univeristy Hospital
Sun Yat-sen University
Mackay Memorial Hospital
Far Easter Memorial Hospital
Cathay General Hospital
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT01257100
First received: December 8, 2010
Last updated: July 11, 2014
Last verified: June 2014
  Purpose

Background:

- Nasopharyngeal carcinoma (NPC) a common malignant tumor in southern China and Southeast Asia. Infection with Epstein-Barr virus is believed to be necessary for the development of NPC; non-viral environmental factors, such as dietary consumption of nitrosamines, cigarette smoking, betel nut chewing, wood dust exposure and possibly exposure to formaldehyde, have been implicated in the disease. Genetic susceptibility may also play an important role in the development of NPC. However, more information is needed on the connections between genetic and environmental factors in NPC, particularly in areas where the cancer risk appears to be greatest.

Objectives:

- To examine the main effects of genetic factors and environmental exposures (e.g., cigarette smoking, betel nut chewing, formaldehyde, wood dust) on nasopharyngeal carcinoma risk.

Eligibility:

  • Cases: Individuals at least 21 years of age who have been diagnosed with NPC at one of the participating hospitals and have been residents of northern Taiwan for at least 6 months.
  • Controls: Hospital patients with diseases other than NPC at least 21 years of age, matched to NPC patients based on hospital, age at diagnosis, gender, and ethnicity.

Design:

  • This study involves a risk factor interview, medical record abstraction and biological sample collection.
  • Participants will respond to interview questions about their lifestyle and risk factors thought to be involved in NPC development.
  • All participants will provide blood and saliva samples for study. Participants who have been diagnosed with NPC will also provide consent to allow researchers to study tissue samples taken during tumor biopsies or surgeries.
  • Treatment will not be provided as part of this protocol.

Condition
Nasopharyngeal Neoplasms
Herpesvirus 4, Human

Study Type: Observational
Official Title: Environmental and Genetic Determinants of NPC

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Primary Outcome Measures:
  • Nasopharyngeal carcinoma

Estimated Enrollment: 4000
Study Start Date: November 2010
Detailed Description:

Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumors in southern China and Southeast Asia. While infection with Epstein-Barr Virus (EBV) is believed to be necessary for the development of NPC, non-viral environmental factors have also been implicated in the carcinogenesis of NPC including consumption of salted fish and other nitrosamine containing preserved foods, formaldehyde and wood dust exposure, cigarette smoking, and betel nut chewing. In addition to environmental factors, it is widely accepted that genetic susceptibility plays an important role in the pathogenesis of NPC. Polymorphisms in genes involved in antigen presentation, nitrosamine metabolism and DNA repair have been suggested to be associated with NPC risk, and various chromosomal regions linked to NPC development have been reported. Two recently completed NPC GWAS have reported that the strongest evidence for disease association is observed for SNPs located on the 3.6 Mb Major Histocompatibility Complex (MHC) region on chromosome 6p21 where human leukocyte antigen (HLA) genes are located. These associations highlight the role of both environmental exposures and genomic variation in the etiology of NPC. However, the specific role of EBV on NPC pathogenesis is not completely understood and studies to date have had difficulty pinpointing the specific genetic factors involved in NPC pathogenesis due to the complexity of the MHC region and limited sample size of candidate gene studies.

DCEG investigators and their Taiwan colleagues have a longstanding history of studies to elucidate the role of environmental and genetic factors associated with NPC. A case-control study (375 cases; 327 controls) was conducted in the early 1990s and was followed by a large multiplex family study that was completed in 2006 (358 families; 3,216 individuals). Results from these studies have provided a substantial portion of the epidemiological evidence regarding factors linked to NPC development to date.

At this time, we propose a new case-control study in Taiwan designed to 1) comprehensively evaluate environmental risk factors for NPC; 2) systematically evaluate genetic risk factors for NPC for which previous GWAS and candidate-gene studies have suggested an association; and 3) explore gene-gene and gene-environment interactions for strong main effects identified in our study. In total, up to 2000 cases and 2000 controls are expected to be recruited from five participating hospitals in Northern Taiwan. Cases will consist of 550 incident cases ascertained retrospectively and 1350 incident cases ascertained prospectively. Controls will be hospital based; they will be frequency matched (1:1) to cases on age, gender and ethnicity, and will exclude individuals referred to the participating hospitals due to conditions associated with known NPC risk factors.

This project is a collaborative effort between investigators in Taiwan and at the NCI. Investigators in Taiwan will fund the field recruitment and data collection effort. Results from this study have the potential to further clarify currently controversial environmental risk factors as well as elucidate genetic factors of NPC.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria
  • INCLUSION CRITERIA:

Eligibility criteria for cases:

  • Incident diagnosis of NPC between 2010-2015
  • Age greater than or equal to 21 years at NPC diagnosis
  • Histologically confirmed
  • Resident of northern Taiwan greater than or equal to 6 months

Eligibility criteria for controls:

  • Resident of northern Taiwan greater than or equal to 6 months
  • Matched to case based on age at diagnosis, gender, and ethnicity

EXCLUSION CRITERIA:

Exclusion criteria for controls:

- Clinic attendance due to conditions associated with EBV or smoking

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01257100

Contacts
Contact: Kelly J Yu (301) 594-7642 yuke@mail.nih.gov
Contact: Allan Hildesheim, Ph.D. (301) 451-3984 hildesha@exchange.nih.gov

Locations
Taiwan
Academia Sinica 128 Academia Road Recruiting
Taipei, Taiwan
Cathay General Hospital 280 Renai Rd, Section 4 Recruiting
Taipei, Taiwan
Far Easter Memorial Hospital 21, NanYa S. Rd, Section 2, Ban-Chiao Recruiting
Taipei, Taiwan
National Taiwan University Hospital Recruiting
Taipei, Taiwan
Koo Foundation Sun Yat-Sen Cancer Center Recruiting
Taipei City, Taiwan
MacKay Memorial Hospital No 92, Section 2, Zhongshan N. Rd, Zhongshan Dist Recruiting
Taipei City, Taiwan
Sponsors and Collaborators
Academia Sinica
National Taiwan Univeristy Hospital
Sun Yat-sen University
Mackay Memorial Hospital
Far Easter Memorial Hospital
Cathay General Hospital
Investigators
Principal Investigator: Allan Hildesheim, Ph.D. National Cancer Institute (NCI)
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT01257100     History of Changes
Other Study ID Numbers: 999911040, 11-C-N040
Study First Received: December 8, 2010
Last Updated: July 11, 2014
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Nasopharyngeal Carcinoma
Epstein-Barr Virus
NPC

Additional relevant MeSH terms:
Nasopharyngeal Neoplasms
Head and Neck Neoplasms
Nasopharyngeal Diseases
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pharyngeal Diseases
Pharyngeal Neoplasms
Stomatognathic Diseases

ClinicalTrials.gov processed this record on October 23, 2014